Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation

• Principais autores: Yanmin Zhao (Autor), Guifang OuYang (Autor), Jimin Shi (Autor), Yi Luo (Autor), Yamin Tan (Autor), Jian Yu (Autor), Huarui Fu (Autor), Xiaoyu Lai (Autor), Lizhen Liu (Autor), He Huang (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Bronchiolitis obliterans syndrome (BOS) is a life-threatening pulmonary manifestation of chronic graft versus host disease (cGVHD) post-allogeneic hematopoietic stem cell transplantation (HSCT), without clear standard of care. This study included 30 patients undergoing an allogeneic HSCT for a hemat...